Skip to main content
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.7738
-0.0462 (-5.63%)
At close: Nov 13, 2026, 4:00 PM EST
0.7678
-0.0060 (-0.78%)
After-hours: Nov 13, 2026, 7:18 PM EST

Compass Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.85---
Revenue Growth
------
Gross Profit
--0.85---
Selling, General & Admin
25.416.8715.1312.2411.6610.93
Research & Development
68.6755.9742.3438.123020.34
Operating Expenses
94.0772.8457.4850.3641.6631.26
Operating Income
-94.07-72.84-56.63-50.36-41.66-31.26
Interest Expense
------0.37
Interest & Investment Income
7.716.357.257.872.360.03
EBT Excluding Unusual Items
-86.36-66.49-49.38-42.49-39.3-31.61
Gain (Loss) on Sale of Assets
----0.070.04
Pretax Income
-86.36-66.49-49.38-42.49-39.23-82.18
Net Income
-86.36-66.49-49.38-42.49-39.23-82.18
Net Income to Common
-86.36-66.49-49.38-42.49-39.23-82.18
Net Income Growth
------
Shares Outstanding (Basic)
18615813712710563
Shares Outstanding (Diluted)
18615813712710563
Shares Change
27.73%14.78%8.15%20.76%67.31%104.28%
EPS (Basic)
-0.46-0.42-0.36-0.33-0.37-1.31
EPS (Diluted)
-0.46-0.42-0.36-0.33-0.37-1.31
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-61.94-49.17-44.9-40.65-34.34-21.55
Free Cash Flow Per Share
-0.33-0.31-0.33-0.32-0.33-0.34
Gross Margin
--100.00%---
Operating Margin
---6661.76%---
Profit Margin
---5808.82%---
Free Cash Flow Margin
---5282.23%---
EBITDA
-93.99-72.56-56.04-49.66-40.87-30.7
D&A For EBITDA
0.080.280.590.70.780.57
EBIT
-94.07-72.84-56.63-50.36-41.66-31.26
SEC Filings: 10-K · 10-Q